Aquatic Capital Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Aquatic Capital Management’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-300	Closed	-$1.23K	–	1624
2024 Q1	$1.23K	Buy	+300	New	+$1.2K	﹤0.01%	1169
2023 Q4	–	Sell	-4,200	Closed	-$18K	–	1658
2023 Q3	$18K	Sell	4,200 -1,500	-26%	-$8.33K	﹤0.01%	1086
2023 Q2	$38K	Sell	5,700 -2,800	-33%	-$17.9K	﹤0.01%	1043
2023 Q1	$58K	Sell	8,500 -10,400	-55%	-$73.1K	﹤0.01%	862
2022 Q4	$140K	Buy	18,900 +12,600	+200%	+$123K	0.01%	812
2022 Q3	$62K	Buy	+6,300	New	+$66.5K	0.01%	850
2022 Q2	–	Sell	-1,300	Closed	-$15K	–	1590
2022 Q1	$15K	Buy	+1,300	New	+$17.1K	0.02%	573

Other funds holding VNDA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aquatic Capital Management's VNDA Position: Q2 2024 in Review

Aquatic Capital Management sold out of Vanda Pharmaceuticals (VNDA) in Q2 2024, closing a stake of 300 shares — an estimated $1.23K sold.

Aquatic Capital Management first reported a position in VNDA in Q1 2022 and held it in 7 quarters. The position peaked at $140K in Q4 2022. 148 funds tracked by Wall St. Rank hold VNDA as of Q2 2024.

Aquatic Capital Management reported no remaining Vanda Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
Aquatic Capital Management sold 300 Vanda Pharmaceuticals shares in Q2 2024, an estimated $1.23K.
Aquatic Capital Management first reported a position in Vanda Pharmaceuticals in Q1 2022 and held it in 7 quarters.
Aquatic Capital Management's Vanda Pharmaceuticals position peaked at $140K in Q4 2022.
148 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2024.

Based on Aquatic Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.